Incyte is gunning for a first-in-class nod for PD-1 inhibitor Zynyz in anal cancer again after being turned away by the FDA ...

One of BioNTech's first mRNA cancer vaccine candidates has cleared a key mid-stage trial, setting it up for a potential ...

The fight against cancer is seeing a revolutionary shift with the emergence of PD-1/PD-L1 Inhibitors. These groundbreaking ...

After a meeting with the FDA last week, Elevar Therapeutics and Jiangsu Hengrui Pharma are preparing to refile their PD-1 combination around the end of September or October, the two companies ...

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets thought to protect ...

Independence voters signed off on a 1/4-cent sales tax to fund raises for city police officers on Tuesday night.

The overall survival of laryngeal squamous cell carcinoma (LSCC) hasn't changed significantly in the last decades, leading to a negative prognosis in advanced stages. So, the immunotherapy takes space ...

For the second quarter in a row, Incyte has used its earnings results to significantly slim down its early-stage pipeline as ...

Additionally, the data show that systemic administration of INT-1B3 to 4T1 and H22 tumor bearing immunocompetent mice prolonged animal survival by reducing metastasis compared to phosphate buffered ...

A new research paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "INT-1B3, an LNP formulated miR-193a ...

A research paper has been published in Oncotarget titled, "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor ...

Chicago PD’s revolving door cast is unavoidable. When you have a series that has been on the air for over a … Jesse Lee Soffer will be joining the cast of FBI: International for the show’s ...